Echocardiography: Value and Accuracy at REst and STress
Launched by UNIVERSITY OF OXFORD · Sep 14, 2018
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Study Overview:
• Design
EVAREST is a multi-centre observational study comparing accuracy of novel quantitative stress echocardiography biomarkers for prediction of 12 month outcome against standard clinical interpretation.
• Scientific Justification
Coronary artery disease affects 2.3 million people in the UK and is responsible for 66 000 deaths each (BHF, 2018). As such, early diagnosis and intervention is crucial for saving lives and improving people's quality of life. Stress echocardiography is a commonly used, non-invasive imaging test used for detection of prognostically significa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be undergoing a stress echocardiogram to investigate the presence of ischaemic heart disease (groups 1-3).
- • Patients must be able to provide informed consent.
- • Patients must be aged over 18 years of age.
- Exclusion Criteria:
- • Patients undergoing stress echocardiography to assess valvular function.
- • Patients who are unwilling or unable to provide informed consent.
- • Patients aged under 18 years of age.
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Paul Leeson
Principal Investigator
Cardiovascular Clinical Research Facility, University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials